1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
After 6 years with Xolair; a 3-year withdrawal follow-up
Nopp, A. ; Johansson, S. G. O. ; Adedoyin, J. ; Ankerst, Jaro LU
; Palmqvist, M.
and Oman, H.
(2010)
In Allergy
65(1).
p.56-60
- Contribution to journal › Article
- 2007
-
Mark
CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment
Nopp, A. ; Johansson, S. G. O. ; Ankerst, Jaro LU
; Palmqvist, M.
and Oman, H.
(2007)
In Allergy
62(10).
p.1175-1181
- Contribution to journal › Article
- 2006
-
Mark
Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation
Nopp, A ; Johansson, SGO ; Ankerst, Jaro LU
; Bylin, G
; Cardell, Lars-Olaf
LU
; Gronneberg, R
; Irander, K
; Palmqvist, M
and Oman, H
(2006)
In Allergy
61(3).
p.298-302
- Contribution to journal › Article
- 2005
-
Mark
The effect of formoterol over 24 h in patients with asthma: the role of enantiomers
Lotvall, J ; Palmqvist, M ; Ankerst, Jaro LU
; Persson, G
; Rosenborg, J
; Bengtsson, T
; Rott, Z
; Poczi, M
; Devai, A
and Waldeck, B
(2005)
In Pulmonary Pharmacology & Therapeutics
18(2).
p.109-113
- Contribution to journal › Article
- 2003
-
Mark
Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.
- Contribution to journal › Article
- 2001
-
Mark
Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis
Vilsvik, J ; Ankerst, Jaro LU
; Palmqvist, M
; Persson, G
; Schaanning, J
; Schwabe, G
and Johansson, A
(2001)
In Respiratory Medicine
95(6).
p.484-490
- Contribution to journal › Article